Developer docs
API playgroundTry for free, no card

Search company profiles

Roboligent

Full company profile

uuid0002guj

Namestring
Roboligent
Legal namestring
Roboligent Inc.
Websiteurl
roboligent.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Roboligent Inc. is a private U.S. robotics company, founded in 2016–2017 and headquartered in Round Rock, Texas, that develops AI-powered soft-robotics platforms built around precision force-control actuators. Its commercial portfolio comprises two products: ROBIN, a mobile bimanual humanoid robot combining autonomous mobile robot navigation with dual-arm soft manipulation for smart factory machine tending, teleoperation, logistics, and warehouse tasks; and REGEN, a 7-DOF force-controlled medical rehabilitation device that automates physical therapy using Teach-and-Follow programming and an Assist-as-Needed protocol for stroke and neuromuscular patients. Both products rely on imitation learning, computer vision, and multimodal AI to enable safe human-robot interaction and rapid task adaptation from demonstration.

The company's revenue model is a mix of capital equipment hardware sales (ROBIN to manufacturers, REGEN to hospitals and rehabilitation centers), U.S. government R&D contracts via the SBIR/STTR programs (notably AFWERX), and potential licensing of its force-control and soft manipulator patents. Go-to-market is sales-led and enterprise-oriented: direct field sales to U.S. manufacturers, healthcare institutions, and defense agencies for ROBIN and REGEN respectively, augmented by strategic partnerships with Korean firms (Tesollo, Aidin Robotics, Goseong Engineering) for joint product development and Asian/North American market entry, and by ecosystem relationships with Johnson & Johnson JLABS @ TMC, UT Austin, Texas Medical Center Innovation, and Changi General Hospital (Singapore). Customer concentration is high, anchored on the $1.8M AFWERX STTR Phase II contract (Sep 2024–2026) and a small number of PoC and pipeline relationships, with mass-production verification of ROBIN underway with a major Korean conglomerate as of late 2025.

Short descriptiontext

Roboligent develops AI-powered soft robotics platforms: ROBIN, a mobile bimanual humanoid for smart factory automation, and REGEN, a 7-DOF force-controlled rehabilitation device, sold to manufacturers, hospitals, and U.S. defense agencies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRound Rock, United States
HQ citystring
Round Rock
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
soft robotics systems, humanoid manufacturing robots, rehabilitation robotics devices, force-controlled automation, AI mobile manipulators
Industry4 codes
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHDAAAIAJ
Humanoid & General-Purpose Robots
SECONDARYIMAHAHAA
Industrial Robots (Articulated, SCARA, Delta, Cartesian)
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Industrial Robotics / Collaborative Robots
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Humanoid Robot Sales (ROBIN)
TypeHardware Sales
Description

Sale of ROBIN mobile humanoid robots for smart factory automation, including machine tending, teleoperation, and logistics applications. Revenue is generated through direct enterprise sales of robotic systems.

roboligent.com
2Rehabilitation Robot Sales (REGEN)
TypeHardware Sales
Description

Sale of REGEN robotic rehabilitation systems to hospitals, clinics, and rehabilitation centers. Regen is a medical device designed for clinical environments, operated by qualified technicians or therapists.

roboligent.com
3Government / Defense Contracts (STTR/SBIR)
TypeOthers
Description

Revenue from U.S. Department of the Air Force STTR Phase II contract ($1.8MM) focused on advanced robotic-assisted rehabilitation technology. The goal is preferential deployment to US military hospitals after project completion.

roboligent.com
4Licensing / Technology Partnerships
TypeLicensing Royalties
Description

Revenue potential through licensing of proprietary force-control technology, soft manipulator patents, and co-development partnerships with strategic partners for global market expansion.

roboligent.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1No public pricing available
ModelOtherBilling cadenceOther
Notes

Pricing is not publicly listed. The company uses a 'Contact Us' form for inquiries, suggesting a quote-based sales model typical of enterprise robotics hardware sales.

roboligent.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1ROBIN
Description

Mobile humanoid robot with soft robot and imitation learning technology, designed for smart factory automation with AI-driven navigation, object recognition, and bimanual manipulation capabilities.

roboligent.com
+1 more record
Core offering1 text field

Roboligent designs and sells AI-powered mobile humanoid robots built on patented soft-robotics and force-control technology. Its two flagship products are ROBIN, a mobile bimanual humanoid for smart-factory automation (machine tending, logistics, teleoperation), and REGEN, a 7-DOF force-controlled medical device that automates physical therapy exercises for patients with neuromuscular impairments.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 60% Therapy Intensity Increase
+2 more records
Product overview1 text field

Roboligent develops AI-powered mobile manipulator robots (humanoid robots) that seamlessly integrate with human workflows for manufacturing and healthcare applications. The product portfolio centers on two core platforms: ROBIN, a mobile bimanual humanoid robot for smart factory automation including machine tending, logistics, and warehouse operations; and REGEN, a rehabilitation robot for automating physical therapy exercises. Both products leverage proprietary force-controlled 'soft robot' technology and AI capabilities including imitation learning, autonomous navigation, and computer vision for adaptive, safe human-robot interaction.

Product and service2 records
1ROBIN
CategoryMobile humanoid manufacturing robot
Description

ROBIN is an AI-powered mobile bimanual humanoid robot with patented soft robotics and force-controlled actuators, built for manufacturing automation, machine tending, material handling, teleoperation, and warehouse logistics. It uses imitation learning so operators can teach tasks by demonstration, enabling safe human-robot collaboration without cages.

2REGEN
CategoryRehabilitation medical robot
Description

REGEN is a medical device that automates physical therapy exercises for patients with neuromuscular impairments. It features a 7-degree-of-freedom force-controlled robot covering a full 6D motional space, supports upper-limb, lower-limb, and gait training, uses Teach-and-Follow programming and an Assist-as-Needed (AAN) protocol, and provides quantitative, data-driven progress tracking for clinical environments operated by therapists and technicians.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-05
Description

Strategic partnership for joint product development, component supply and solution co-creation, and global market expansion. Aidin Robotics brings high-performance, cost-competitive force/torque sensors and humanoid robot parts, while Roboligent contributes AI and soft manipulation technology. Both companies plan cross-sales and joint marketing efforts, aiming to position themselves among Top Tier robotics companies worldwide.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-14
Description

Roboligent signed a Memorandum of Understanding (MoU) with Tesollo, a robot hand-based automation solutions specialist. The partnership aims to develop innovative robot solutions by combining Roboligent's AI-based precision flexible robot arm technology with Tesollo's multi-DOF human-like robot hand technology. Cooperation areas include technology sharing and joint research, product portfolio expansion, and global market expansion collaboration across Asia and North America. The partnership resulted in a joint showcase at RobotWorld 2025.

3Goseong Engineering
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-05
Description

Goseong Engineering made a strategic investment in Roboligent to develop AI-integrated robots and expand into overseas smart factory markets, particularly North America. The collaboration combines Goseong's automation solutions with Roboligent's force control technology. Goseong also plans to establish smart factories in the U.S. as part of its expansion strategy.

zdnet.co.kr
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-16
Description

Roboligent was selected as a resident company of JLABS @ TMC (Texas Medical Center), a global network of open innovation ecosystems. The residency is intended to accelerate the innovation and commercialization of Roboligent's first commercialized product, the Regen rehabilitation therapy automation robot.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-14
Description

Collaboration with the Human Centered Robotics laboratory at the University of Texas to develop advanced rehabilitation control policies using supervised machine learning techniques for the AFWERX STTR project.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint project in pipeline with Changi General Hospital in Singapore for robotic rehabilitation technology deployment. Part of Roboligent's commercialization strategy driven by public sectors in the US, Korea, and Singapore.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

TMC Innovation is a partner supporting Roboligent through the JLABS residency, providing access to the world's largest medical city ecosystem for healthcare robotics development and commercialization.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Austin, Texas-based humanoid robotics company building general-purpose humanoids (Apollo) for industrial and manufacturing applications. Direct competitor in the same geography targeting the same factory-automation use case as Roboligent's ROBIN.

TypeBroad incumbent
Description

Tesla's humanoid robot program (Optimus) targets manufacturing labor automation within Tesla's own factories and eventually broader industrial use. Large incumbent competing for the same industrial humanoid opportunity as Roboligent's ROBIN, with vastly more capital and manufacturing capacity.

TypeBroad incumbent
Description

Established robotics pioneer (Spot, Stretch, Atlas) with broader industrial and research portfolio owned by Hyundai. Competitor in mobile manipulation and humanoid robotics but operates across many verticals beyond Roboligent's smart-factory and rehabilitation focus.

TypeDirect peer
Description

Norwegian humanoid robotics company developing NEO, a bipedal humanoid for home and commercial service applications. Direct competitor in AI-driven humanoid manipulation with backing from OpenAI.

5Hocoma (DIH Medical)
TypeDirect peer
Description

Swiss-based global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for clinical and research use. Direct competitor to REGEN in the rehabilitation robotics space with established hospital installed base and FDA clearances.

TypeDirect peer
Description

Niche rehabilitation and exoskeleton company developing robotic devices for stroke and spinal cord injury rehabilitation, including the EksoNR. Direct competitor to REGEN in robotic rehabilitation therapy for clinical settings.

TypeDirect peer
Description

Canadian developer of Phoenix, a general-purpose humanoid robot with Carbon AI control system, focused on industrial manipulation tasks. Direct competitor in AI-powered humanoid manipulation for labor-shortage applications.

TypeDirect peer
Description

Shanghai/Singapore-based rehabilitation robotics company developing intelligent therapy robots for stroke and neuromuscular rehabilitation, including the GR-1 humanoid. Direct competitor to REGEN in rehabilitation robotics with established hospital footprint in Asia.

TypeDirect peer
Description

Developer of the Figure 01/02 general-purpose humanoid robot aimed at manufacturing and warehouse labor-shortage applications. Direct competitor in industrial humanoid robotics with substantially more capital and partnerships (BMW, OpenAI).

TypeDirect peer
Description

Creator of Digit, a bipedal humanoid robot focused on logistics and warehouse automation, with commercial deployments at Amazon and GXO. Direct peer in mobile manipulation for industrial settings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Roboligent

Industrial Robotics / Collaborative Robotsroboligent.com

Roboligent develops AI-powered soft robotics platforms: ROBIN, a mobile bimanual humanoid for smart factory automation, and REGEN, a 7-DOF force-controlled rehabilitation device, sold to manufacturers, hospitals, and U.S. defense agencies.

What Roboligent does

Roboligent Inc. is a private U.S. robotics company, founded in 2016–2017 and headquartered in Round Rock, Texas, that develops AI-powered soft-robotics platforms built around precision force-control actuators. Its commercial portfolio comprises two products: ROBIN, a mobile bimanual humanoid robot combining autonomous mobile robot navigation with dual-arm soft manipulation for smart factory machine tending, teleoperation, logistics, and warehouse tasks; and REGEN, a 7-DOF force-controlled medical rehabilitation device that automates physical therapy using Teach-and-Follow programming and an Assist-as-Needed protocol for stroke and neuromuscular patients. Both products rely on imitation learning, computer vision, and multimodal AI to enable safe human-robot interaction and rapid task adaptation from demonstration.

The company's revenue model is a mix of capital equipment hardware sales (ROBIN to manufacturers, REGEN to hospitals and rehabilitation centers), U.S. government R&D contracts via the SBIR/STTR programs (notably AFWERX), and potential licensing of its force-control and soft manipulator patents. Go-to-market is sales-led and enterprise-oriented: direct field sales to U.S. manufacturers, healthcare institutions, and defense agencies for ROBIN and REGEN respectively, augmented by strategic partnerships with Korean firms (Tesollo, Aidin Robotics, Goseong Engineering) for joint product development and Asian/North American market entry, and by ecosystem relationships with Johnson & Johnson JLABS @ TMC, UT Austin, Texas Medical Center Innovation, and Changi General Hospital (Singapore). Customer concentration is high, anchored on the $1.8M AFWERX STTR Phase II contract (Sep 2024–2026) and a small number of PoC and pipeline relationships, with mass-production verification of ROBIN underway with a major Korean conglomerate as of late 2025.

Roboligent firmographics

Firmographics
Name
Roboligent
Legal name
Roboligent Inc.
Website
https://roboligent.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Roboligent develops AI-powered soft robotics platforms: ROBIN, a mobile bimanual humanoid for smart factory automation, and REGEN, a 7-DOF force-controlled rehabilitation device, sold to manufacturers, hospitals, and U.S. defense agencies.
Ownership category
akta.pro rank

Roboligent industry classification

Industry
Product category
Industrial Robotics / Collaborative Robots
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHDAAAIAJ
Humanoid & General-Purpose Robots
SECONDARYIMAHAHAA
Industrial Robots (Articulated, SCARA, Delta, Cartesian)
SECONDARYHDAAAIAL
Robot Hardware, Actuators & Components (sensors, grippers, motors)

Keywords

  • Soft robotics systems
  • Humanoid manufacturing robots
  • Rehabilitation robotics devices
  • Force-controlled automation
  • AI mobile manipulators

Where Roboligent is headquartered

Location

Headquarters

HQ city
Round Rock
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Roboligent business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Humanoid Robot Sales (ROBIN): Sale of ROBIN mobile humanoid robots for smart factory automation, including machine tending, teleoperation, and logistics applications. Revenue is generated through direct enterprise sales of robotic systems.
  2. Rehabilitation Robot Sales (REGEN): Sale of REGEN robotic rehabilitation systems to hospitals, clinics, and rehabilitation centers. Regen is a medical device designed for clinical environments, operated by qualified technicians or therapists.
  3. Government / Defense Contracts (STTR/SBIR): Revenue from U.S. Department of the Air Force STTR Phase II contract ($1.8MM) focused on advanced robotic-assisted rehabilitation technology. The goal is preferential deployment to US military hospitals after project completion.
  4. Licensing / Technology Partnerships: Revenue potential through licensing of proprietary force-control technology, soft manipulator patents, and co-development partnerships with strategic partners for global market expansion.

Pricing tiers

ModelBillingPrice
OtherOtherNo public pricing available

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Roboligent product offering

Product offering

Core offering

Roboligent designs and sells AI-powered mobile humanoid robots built on patented soft-robotics and force-control technology. Its two flagship products are ROBIN, a mobile bimanual humanoid for smart-factory automation (machine tending, logistics, teleoperation), and REGEN, a 7-DOF force-controlled medical device that automates physical therapy exercises for patients with neuromuscular impairments.

Product overview

Roboligent develops AI-powered mobile manipulator robots (humanoid robots) that seamlessly integrate with human workflows for manufacturing and healthcare applications. The product portfolio centers on two core platforms: ROBIN, a mobile bimanual humanoid robot for smart factory automation including machine tending, logistics, and warehouse operations; and REGEN, a rehabilitation robot for automating physical therapy exercises. Both products leverage proprietary force-controlled 'soft robot' technology and AI capabilities including imitation learning, autonomous navigation, and computer vision for adaptive, safe human-robot interaction.

Differentiator

Problem solved

Functional benefit

Brands

  • ROBIN: Mobile humanoid robot with soft robot and imitation learning technology, designed for smart factory automation with AI-driven navigation, object recognition, and bimanual manipulation capabilities.
  • REGEN

Products and services

  • ROBIN ROBIN is an AI-powered mobile bimanual humanoid robot with patented soft robotics and force-controlled actuators, built for manufacturing automation, machine tending, material handling, teleoperation, and warehouse logistics. It uses imitation learning so operators can teach tasks by demonstration, enabling safe human-robot collaboration without cages.
  • REGEN REGEN is a medical device that automates physical therapy exercises for patients with neuromuscular impairments. It features a 7-degree-of-freedom force-controlled robot covering a full 6D motional space, supports upper-limb, lower-limb, and gait training, uses Teach-and-Follow programming and an Assist-as-Needed (AAN) protocol, and provides quantitative, data-driven progress tracking for clinical environments operated by therapists and technicians.

Quantifiable outcome

  • 60% Therapy Intensity Increase
  • +2 more outcomes

Companies that use Roboligent

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Roboligent technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Roboligent partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and major.

  • Aidin RoboticscoreTechnology or Integration · 5 September 2025Strategic partnership for joint product development, component supply and solution co-creation, and global market expansion. Aidin Robotics brings high-performance, cost-competitive force/torque sensors and humanoid robot parts, while Roboligent contributes AI and soft manipulation technology. Both companies plan cross-sales and joint marketing efforts, aiming to position themselves among Top Tier robotics companies worldwide.
  • TesollocoreTechnology or Integration · 14 August 2025Roboligent signed a Memorandum of Understanding (MoU) with Tesollo, a robot hand-based automation solutions specialist. The partnership aims to develop innovative robot solutions by combining Roboligent's AI-based precision flexible robot arm technology with Tesollo's multi-DOF human-like robot hand technology. Cooperation areas include technology sharing and joint research, product portfolio expansion, and global market expansion collaboration across Asia and North America. The partnership resulted in a joint showcase at RobotWorld 2025.
  • Goseong EngineeringcoreStrategic or Co-development Partner · 5 September 2024Goseong Engineering made a strategic investment in Roboligent to develop AI-integrated robots and expand into overseas smart factory markets, particularly North America. The collaboration combines Goseong's automation solutions with Roboligent's force control technology. Goseong also plans to establish smart factories in the U.S. as part of its expansion strategy.
  • Johnson & Johnson Innovation – JLABS @ TMCcoreStrategic or Co-development Partner · 16 November 2023Roboligent was selected as a resident company of JLABS @ TMC (Texas Medical Center), a global network of open innovation ecosystems. The residency is intended to accelerate the innovation and commercialization of Roboligent's first commercialized product, the Regen rehabilitation therapy automation robot.
  • University of Texas at Austin / Human Centered Robotics LabcoreStrategic or Co-development Partner · 14 April 2023Collaboration with the Human Centered Robotics laboratory at the University of Texas to develop advanced rehabilitation control policies using supervised machine learning techniques for the AFWERX STTR project.
  • Changi General Hospital (Singapore)majorStrategic or Co-development PartnerJoint project in pipeline with Changi General Hospital in Singapore for robotic rehabilitation technology deployment. Part of Roboligent's commercialization strategy driven by public sectors in the US, Korea, and Singapore.
  • Texas Medical Center (TMC) InnovationcoreStrategic or Co-development PartnerTMC Innovation is a partner supporting Roboligent through the JLABS residency, providing access to the world's largest medical city ecosystem for healthcare robotics development and commercialization.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Roboligent competitors and assessment

Company assessment

Direct peers

  • Apptronik: Austin, Texas-based humanoid robotics company building general-purpose humanoids (Apollo) for industrial and manufacturing applications. Direct competitor in the same geography targeting the same factory-automation use case as Roboligent's ROBIN.
  • 1X Technologies: Norwegian humanoid robotics company developing NEO, a bipedal humanoid for home and commercial service applications. Direct competitor in AI-driven humanoid manipulation with backing from OpenAI.
  • Hocoma (DIH Medical): Swiss-based global leader in robotic and sensor-based rehabilitation devices (Lokomat, Armeo) for clinical and research use. Direct competitor to REGEN in the rehabilitation robotics space with established hospital installed base and FDA clearances.
  • Ekso Bionics: Niche rehabilitation and exoskeleton company developing robotic devices for stroke and spinal cord injury rehabilitation, including the EksoNR. Direct competitor to REGEN in robotic rehabilitation therapy for clinical settings.
  • Sanctuary AI: Canadian developer of Phoenix, a general-purpose humanoid robot with Carbon AI control system, focused on industrial manipulation tasks. Direct competitor in AI-powered humanoid manipulation for labor-shortage applications.
  • Fourier Intelligence: Shanghai/Singapore-based rehabilitation robotics company developing intelligent therapy robots for stroke and neuromuscular rehabilitation, including the GR-1 humanoid. Direct competitor to REGEN in rehabilitation robotics with established hospital footprint in Asia.
  • Figure AI: Developer of the Figure 01/02 general-purpose humanoid robot aimed at manufacturing and warehouse labor-shortage applications. Direct competitor in industrial humanoid robotics with substantially more capital and partnerships (BMW, OpenAI).
  • Agility Robotics: Creator of Digit, a bipedal humanoid robot focused on logistics and warehouse automation, with commercial deployments at Amazon and GXO. Direct peer in mobile manipulation for industrial settings.

Broad incumbents

  • Tesla (Optimus): Tesla's humanoid robot program (Optimus) targets manufacturing labor automation within Tesla's own factories and eventually broader industrial use. Large incumbent competing for the same industrial humanoid opportunity as Roboligent's ROBIN, with vastly more capital and manufacturing capacity.
  • Boston Dynamics: Established robotics pioneer (Spot, Stretch, Atlas) with broader industrial and research portfolio owned by Hyundai. Competitor in mobile manipulation and humanoid robotics but operates across many verticals beyond Roboligent's smart-factory and rehabilitation focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Roboligent social profiles

Digital presence

Roboligent financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Roboligent leadership team

Management profile

Number of profiles

Profiles1 record

Roboligent funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Roboligent M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roboligent

What does Roboligent do?

Roboligent designs and sells AI-powered mobile humanoid robots built on patented soft-robotics and force-control technology. Its two flagship products are ROBIN, a mobile bimanual humanoid for smart-factory automation (machine tending, logistics, teleoperation), and REGEN, a 7-DOF force-controlled medical device that automates physical therapy exercises for patients with neuromuscular impairments.

Is Roboligent a public or private company?

Roboligent is a private company. It is classified as venture growth investor backed and is currently operating.

When was Roboligent founded?

Roboligent was founded in 2017. It employs 11 to 50 people.

Where is Roboligent based?

Roboligent is headquartered in Round Rock, United States, in the North America region.

How does Roboligent make money?

Four revenue lines are on record. Humanoid Robot Sales (ROBIN) is the primary driver. The others are rehabilitation Robot Sales (REGEN), government / Defense Contracts (STTR/SBIR) and licensing / Technology Partnerships.

Who are Roboligent's main competitors?

Direct peers on record are Apptronik, 1X Technologies, Hocoma (DIH Medical), Ekso Bionics, Sanctuary AI, Fourier Intelligence, Figure AI and Agility Robotics. Broad incumbents are Tesla (Optimus) and Boston Dynamics.

Does Roboligent have an API?

No public API is recorded for Roboligent.

What industry is Roboligent in?

Roboligent's product category is Industrial Robotics / Collaborative Robots. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HDAAAIAJ, Humanoid & General-Purpose Robots. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PlatumGoseong Engineering makes a strategic investment in the American robotics company Roboligent.Goseong Engineering has made a strategic investment in American robotics startup Roboligent to facilitate its entry into the overseas smart factory market. The collaboration aims to fuse Goseong's automation solutions with Roboligent's force control technologies to develop AI-equipped mobile manipulators for industrial use. This partnership is expected to support Goseong Engineering in establishing smart factories in the United States and expanding its North American presence.ZdnetGoseong Engineering makes a strategic investment in the American robotics company Roboligent.Goseong Engineering announced a strategic investment in American robotics startup Roboligent to foster cooperation in robot engineering. The two companies plan to jointly develop AI-integrated robots and expand their presence in the overseas smart factory market. This partnership combines Goseong's automation solutions with Roboligent's force control technology.RoboligentRoboligent Joins Johnson & Johnson Innovation – JLABSRoboligent, a company specializing in hyper-precise force control technology for robot service automation, announced on November 16, 2023 that it was selected as a resident company of Johnson & Johnson Innovation – JLABS @ TMC. The company is developing Regen, a rehabilitation therapy automation robot for stroke and other limb rehabilitation, which quantitatively evaluates patient exercise ability.StartEngineInvest in RoboligentA crowdfunding offering page for Roboligent lists a share price of $3.20, a valuation of $28.88 million and a funding goal of $10,000 to $3.5 million, with a deadline of Nov. 30, 2021. Minimum investment is $320 and maximum $106,995.20, with bonuses of up to 10% for early or high-tier investors.